Investigational site # 0103 — Centennial, Colorado

Investigational site # 0103 is a clinical research site located in Centennial, Colorado, United States 80112.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigational site # 0103 has participated in 1 clinical trials.

Therapeutic areas: Primary Immunodeficiency Disease.

Sponsors: Biotest.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Centennial

Browse all research sites in Colorado · View every site in Centennial

• Rocky Mountain Hospital for Children
• Rocky Mountain Cancer Centers Centennial
• IMMUNOe Research Centers
• Research Site
• GSK Investigational Site
• IMMUNOe International Research Centers
• Octapharma Research Site
• Rocky Mountain Cancer Centers LLP
• Novartis Investigative Site
• Ascendis Pharma Investigational Site
• 1st Allergy and Clinical Research Center
• IMMUNOe International Research Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational site # 0103?

Investigational site # 0103 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational site # 0103 conducted?

Investigational site # 0103 has 1 clinical trials on record. Their work covers Primary Immunodeficiency Disease.

Is Investigational site # 0103 accredited by Crixeo Clinical Trials?

Investigational site # 0103 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational site # 0103?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.